TearLab Corp fka TEAR

[Wildbilly]

Q2 2013 Financial Results on August 13, 2013
Conference Call to Follow


SAN DIEGO, July 31, Jul 31, 2013 (GLOBE NEWSWIRE via COMTEX) -- TearLab
Corporation (Nasdaq:TEAR) (TSX:TLB) expects to announce its Q2 2013 financial
results after market closes on Tuesday, August 13, 2013.

TearLab is pleased to invite all willing participants in a conference call
during which time financial results will be discussed. This call will be held at
4:30pm Eastern at 877-303-1593

Date: August 13, 2013

Time: 4:30 PM ET

Listen via Internet: http://www.tearlab.com/investor/

Schedule this webcast into MS-Outlook calendar (click open when prompted):

http://apps.shareholder.com/PNWOutlook/t.aspx?m=60661&k=2FE3F26B

Telephone: [phone]

For those wishing to listen to a recording of the call via telephone, a replay
will be made available by 7:30pm Eastern after the conclusion of the live call
and will remain posted until 11:59pm Eastern on August 20, 2013. To listen to
the recording, simply telephone [phone] (toll free) or 404-537-3406 and
enter conference ID: 27540820 when prompted.

About TearLab Corporation

TearLab Corporation (www.tearlab.com) develops and commercializes lab-on-a-chip
technologies that enable eye care practitioners to improve standard of care by
objectively and quantitatively testing for disease markers in tears at the
point-of-care. The TearLab(r) Osmolarity Test, that enables eye care
practitioners to test for highly sensitive and specific biomarkers using
nanoliters of tear film at the point-of-care, is the first assay developed for
the award winning TearLab Osmolarity System. Headquartered in San Diego, CA,
TearLab Corporation's common shares trade on the NASDAQ Capital Market under the
symbol 'TEAR' and on the Toronto Stock Exchange under the symbol 'TLB'.

Forward-Looking Statements This press release may contain forward-looking
statements. These statements relate to future events and are subject to risks,
uncertainties and assumptions about TearLab. Examples of forward-looking
statements in this press released include predictions regarding the sufficiency
of current cash and cash equivalents to fund operations, building sales in
Europe and Canada, improving third party reimbursement from insurance companies,
and the future commercial adoption of the TearLab Osmolarity System. These
statements are only predictions based on our current expectations and
projections about future events. You should not place undue reliance on these
statements. Actual events or results may differ materially. Many factors may
cause our actual results to differ materially from any forward-looking
statement, including the factors detailed in our filings with the Securities and
Exchange Commission and Canadian securities regulatory authorities, including
but not limited to our annual and quarterly reports on Forms 10-K and 10-Q. We
do not undertake to update any forward-looking statements.



CONTACT: Kilmer Lucas Inc.

         Stephen Kilmer (President)

         905 906-6908 Ext.21

         [e-mail]



         Kilmer Lucas Inc.

         Leonard Zehr (Managing Director)

         905 690 2400 Ext.41

         [e-mail]

http://www.globenewswire.com/newsroom/ti?nf=MTMjMTAwNDI4NzAjMTI1MTI=




(C) Copyright 2013 GlobeNewswire, Inc. All rights reserved.

-0-




KEYWORD:          SAN DIEGO, July 31

INDUSTRY KEYWORD: Healthcare & Medical Services

SUBJECT CODE:     Calendar of Events

                  HEALTH

                   EARNINGS

                   CONFERENCE CALL

Source: Comtex Wall Street News